South Street Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.37M Sell
63,366
-110,635
-64% -$7.64M 0.65% 36
2025
Q1
$12.1M Buy
174,001
+6,840
+4% +$475K 1.98% 23
2024
Q4
$14.4M Sell
167,161
-19,370
-10% -$1.67M 2.2% 20
2024
Q3
$22.2M Sell
186,531
-44,988
-19% -$5.36M 3.37% 8
2024
Q2
$33M Sell
231,519
-3,209
-1% -$458K 5.01% 4
2024
Q1
$30.1M Sell
234,728
-5,099
-2% -$655K 4.81% 4
2023
Q4
$24.8M Sell
239,827
-943
-0.4% -$97.6K 4.64% 5
2023
Q3
$21.9M Buy
240,770
+2,042
+0.9% +$186K 4.4% 4
2023
Q2
$19.3M Sell
238,728
-66,478
-22% -$5.38M 3.83% 6
2023
Q1
$24.3M Buy
305,206
+188
+0.1% +$15K 4.98% 3
2022
Q4
$20.6M Sell
305,018
-7,716
-2% -$522K 4.56% 2
2022
Q3
$15.6M Sell
312,734
-4,710
-1% -$235K 3.84% 6
2022
Q2
$17.7M Buy
317,444
+132,610
+72% +$7.39M 4.03% 2
2022
Q1
$10.3M Buy
+184,834
New +$10.3M 1.94% 26